Carbylan Therapeutics Alternatives & Competitors
12 companies similar to Carbylan Therapeutics — Delivering premier therapies to fast-growing markets with significant clinical n...
Companies similar to Carbylan Therapeutics
IXALTIS SA
DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Autotelic
Enhancing drug development with therapeutic monitoring to increase patent life, expand tre...
Rezolute, Inc.
Rezolute is developing transformative therapeutics for rare and metabolic diseases.
Rival Readout
Competing with Carbylan Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Myogen
Advancing cardiovascular health with innovative small molecule therapeutics for unmet medi...
Visterra Inc.
We bring better biologics to life. Biospace Best Place to Work 2024!
KAMADA
Specialty Plasma-Derived Therapeutics
Reven Pharmaceuticals
Diligently pursuing scientific innovation to exponentially improve health and well-being.
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
OnQuality Pharmaceuticals Ltd.
developing innovative drugs and drug delivery systems that improve the quality of life of...
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
About Carbylan Therapeutics
Carbylan Therapeutics is a clinical-stage specialty pharmaceutical company founded in 2005 with a mission to deliver premier therapies to expanding markets in Health Care and Health and Wellness sectors. Based in Palo Alto, California, the company focuses on developing and commercializing unique combination therapies....
Pharmaceuticals, Specialty Pharmaceuticals, Combination Therapies, Clinical-stage Company, Therapeutics, Drug Development, Commercialization, Unmet Clinical Needs, Clinical Trials, Market Expansion, Palo Alto, California, Biopharmaceuticals, Startup
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Carbylan Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Carbylan Therapeutics on 23 Jun 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.